No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
(e)-1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime |
- |
- |
- |
- |
[1] 161 |
2 |
Botulism toxin treatment |
- |
- |
- |
- |
[1] 161 |
3 |
Celecoxib |
Celecoxib |
D00567 |
[1] PTGS2 |
[20] Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
[8] 2, 3, 34, 46, 70, 89, 161, 271 |
4 |
Lx3305 |
- |
- |
- |
- |
[2] 46, 161 |
5 |
Lx3305 250 mg capsule |
- |
- |
- |
- |
[1] 161 |
6 |
None |
- |
- |
- |
- |
[8] 46, 78, 84, 96, 160, 161, 171, 299 |
7 |
Scenesse |
- |
- |
- |
- |
[1] 161 |